Demographic changes, progress in medicine technology and regional problems in providing healthcare to low density populations are posing great challenges to our healthcare systems. Rapid progress in computer sciences and information technologies have a great impact on the way healthcare will be delivered in the near future. This article describes opportunities and challenges of eHealth and telemedicine in the framework of our health systems and, in particular, in the context of today's cardiology services. The most promising applications of eHealth and telemedicine include: (a) prevention and lifestyle interventions; (b) chronic disease management including hypertension, diabetes and heart failure; (c) arrhythmia detection including early detection of atrial fibrillation and telemonitoring of devices such as pacemaker, internal cardioverter defibrillators and implantable rhythm monitoring devices; (d) telerehabilitation. Major obstacles to the integration of eHealth and telemedicine into daily clinical practice include limited large-scale evidence, in particular, for cost-effectiveness, as well as lack of interoperability, inadequate or fragmented legal frameworks and lack of reimbursement. An important challenge for those involved in these new technologies will be to keep the main focus on patient's individual needs and to carefully evaluate the evidence behind the practice.
Introduction
Our health systems are facing great opportunities and at the same time great challenges. This is due to demographic changes, progress in medicine technology and regional problems in providing healthcare to low density populations. Furthermore, due to the increase of life expectancy and the increasing number of elderly people, there is an increasing need for the care and monitoring of elderly people still living at home and of people with chronic diseases.
eHealth encompasses the use of information and communication technologies (ICTs) in the support of health and health-related activities. 1 eHealth and telemedicine, as they are today, are not only seen as a supplement to the classic health delivery methods but will be integrated into private and public health economy as a main component of modern healthcare. Progress in eHealth and telemedicine is not only driven by health economic factors but in particular by the breathtaking speed of progress in computer sciences and information technology (Table 1) .
However, there are major obstacles to the integration of eHealth and telemedicine into daily clinical practice. First of all, the evidence base for the value of eHealth and telemedicine in managing a wide range of cardiovascular disease is, on the whole, still weak and contradictory. Furthermore, the development of eHealth and telemedicine is still primarily technically driven and not by the needs and expectations of health professionals and patients, and thirdly, common platforms and connectivity between tools and systems are mostly lacking. Furthermore there are major issues in the area of privacy and data security. Last, but not least, there is a lack of business cases, cost efficiency calculations and regulation of reimbursement of eHealth and telemedicine which ultimately may turn out to be one of the biggest obstacles for the introduction of evidence-based eHealth and telemedicine tools into the health delivery system ( Table 2) .
This article provides an overview of the current status of eHealth and telemedicine in cardiovascular care with a main focus on cardiovascular disease prevention, therapy and rehabilitation and summarises the actual base of evidence for the most promising applications.
eHealth
The term eHealth encompasses a range of services or systems that are at the edge of medicine/healthcare and information technology, including: 2 -clinical information systems (electronic medical records, decision support and monitoring clinical and institutional practice); -telemedicine and telecare (including disease management services, remote patient monitoring, teleconsultations and homecare); 3 -integrated regional and national information networks and associated e-referrals and e-prescribing; -disease registries and other non-clinical systems used for education, public health, patient/ mHealth mHealth can be defined as the use of mobile computing and communication technologies for health services and information. 5 It involves the use of mobile phone core functions including voice and short messaging services (SMSs), as well as more complex functions and specialized applications. [5] [6] [7] [8] [9] [10] [11] [12] Smartphones can be linked via Bluetooth technology with health parameter sensors and devices (i.e. glucometers). Use of these devices at the point of care is resulting in a change in the method of healthcare delivery from one that was health-systems generated to one that is remote and patient generated. The culmination of these factors presents unparalleled opportunities to increase patient engagement, to reduce healthcare costs, and to improve outcomes. Interventions may also include a platform where patients can contact their care provider by phone or via a video connection in case they have questions or emergency. The growing mobile phone networks, with increased accessibility providing the opportunity for more personalised and citizen-centred medical care, have been found to lower health system barriers, particularly patient access, as well as reduce healthcare service costs. A recent systematic review shows evidence of improved adherence, as well as health outcomes in disease management using mobile SMS systems and/ or voice calls. 13 Significant improvement has been found on adherence with taking medicine, following diet and physical activity advice, as well as improvement in clinical parameters like glycohemoglobin (HbA1c), blood glucose, blood cholesterol and control of blood pressure and asthma. As mHealth devices are becoming increasingly available, three important questions arise. Who should be the first digital health adopter: the patient, the provider or the healthcare system? What factors of mHealth are most effective? And what is the evidence supporting the clinical utilisation of such devices? A review searching for answers to these questions has recently been published in the European Heart Journal. 8
Telemedicine
The term 'telemedicine' has a wide definition and is considered to be medicine practice at a distance and corresponds to a wide range of telemedicine applications. 3 Telemedicine interactions have been of two types, either taking place in real-time such as for video conferences, or asynchronously such as store and forward transmission of data from home-based measurement of body weight, blood glucose, blood pressure and others. Mobile apps may be either automatic (e.g. passive monitoring of activity using room sensors) or require the patient to do something (e.g. transmitting home-measurement values using conventional telephones or, increasingly and in particular, smartphones).
Educational applications depend on web access from personal computers (PCs) or smartphones and are increasingly applied in medicine for distant learning and information. This application will turn out to be particularly useful for primary and secondary prevention of cardiovascular disease. Another important application includes remote monitoring of devices such as internal cardioverter defibrillators (ICDs) and/or pacemakers. Transmission of data from the device to a central database with the opportunity to survey patients' data, and in particular heart rhythm, has a great potential to increase patients' safety and, hopefully, also comfort. However, the evidence-base for the value of eHealth and telemedicine in managing a wide range of chronic diseases is still weak and contradictory. Promising applications of remote patient monitoring include prevention and lifestyle interventions, control of hypertension, diabetes and heart failure, arrhythmia detection and telerehabilitation (Table 3 ). However, first results from a most recent trial (Remote Management of Heart Failure Using Implantable Electronic Devices -REM-HF) challenges the expectation that remote ICD monitoring add clinical benefit in heart failure patients (oral presentation at ESC meeting 2016).
Prevention and lifestyle interventions
Cardiovascular prevention is the most important intervention in cardiology economically and carries the greatest potential to reduce the burden of cardiovascular disease. Monitoring of cardiovascular risk factors seems to be particularly appealing for the use of telemedicine and in particular health applications to improve lifestyle and adherence to pharmacotherapy by surveillance, education, psychological support and interactive motivational tools i.e. to improve physical activity, healthy nutrition and smoking cessation and thus reduce metabolic risk factors and improve cardiovascular health.
Activity tracking devices are used widely across a variety of contexts. The expansion of activity tracking and personal data collection offers the potential for patient engagement in prevention and management of chronic diseases. Consumer-wearable devices for activity tracking have shown promise in post-surgery recovery in cardiac patients, pulmonary rehabilitation and activity counselling in diabetic patients, among others. Unfortunately, the data generated by wearable devices is seldom integrated into programmatic self-management chronic disease regimens. In addition, there is a lack of evidence supporting sustained use or effects on health outcomes, as studies are primarily focused on establishing the feasibility of monitoring activity and the association of measured activity with short-term benefits. 14 Although smartphone apps and wearable sensors have the potential to help people make healthier lifestyle choices, scientific evidence of mHealth technologies' effectiveness for reducing risk factors for heart disease and stroke is limited, according to a scientific statement from the American Heart Association (AHA). 5 There are several studies in the area of telemonitoring and self-management in the control of hypertension. [15] [16] [17] They show that monitoring blood pressure at a distance is effective and therefore is one of the most promising applications of telemonitoring of cardiovascular risk factors in primary care. However, results in regard to outcome and, in particular, to cost-effectiveness are either controversial or lacking. Table 3 . Most promising application of remote patient monitoring.
Prevention and lifestyle interventions Chronic disease management -Hypertension -Diabetes -Heart failure Arrhythmia detection Telerehabilitation
Telemonitoring and self-management of diabetes is also an area of great interest. Research is somewhat less advanced in this area compared to blood pressure control. And reliable results in regard to feasibility, effects on blood glucose control, prognosis and cost-effectiveness are not yet available.
Furthermore, there are open questions in regard to liability. What are the responsibilities of the patient, what kind of action does he need to take under specific circumstances such as potentially dangerous measurement results and what is the task and responsibility of the telemedical centre or hospital being in charge of data surveillance? Which algorithms should be best used for big data management and for alerts in case of emergencies? Who is paying for what in such a telemedicine system? And will it improve outcome and save money long-term?
Early detection of arrhythmias
For a long time, remote monitoring of heart rhythm has been of interest for prevention of sudden death due to ventricular fibrillation in patients at risk and in patients with devices such as ICDs, pacemakers, Cardiac Resynchronization Therapies (CRT)s and implanted monitoring systems. Another emerging and very promising application of remote monitoring of heart rhythm is early detection of atrial fibrillation (AF).
AF is the most common clinical arrhythmia, which is responsible for at least 15% of strokes, and is the leading cause of stroke among patients >75 years old. [18] [19] [20] Moreover, strokes due to AF are largely avoidable, as the use of oral anticoagulants along with the diagnosis and treatment of hypertension, can prevent >65% of all strokes. Therefore, early detection of AF, assessment of stroke and bleeding risk, and beginning of appropriate prevention are most important components of healthcare not only to reduce the burden of disease but also to reduce health costs. 21, 22 Telemedicine in heart failure Heart failure is a prevalent condition in western societies, affecting 1.5% of the population, and is associated with high hospitalization and readmission rates, high mortality and cost of care. 23 Management of acute and chronic heart failure poses substantial challenges to healthcare systems worldwide. Advances in telecommunication technologies have created opportunities to provide telemedical care as an adjunct to medical management of patients with heart failure.
Feasibility and perception of telemedical care by patients and physicians have been studied in the framework of the Telemedical Interventional Monitoring in Heart Failure (TIM-HF) trial with the objective of proving the superiority of remote patient monitoring compared to guideline-based usual care in terms of total mortality, heart failure hospitalisation, quality of life and other markers of cardiovascular health. 24, 25 Two telemedical centreslocated in two German regions -provided physicianled medical support for 24 h/day, seven days a week, according to defined standard operating procedures. Patients were enrolled from 165 practices in cardiology, internal medicine or general medicine, and were followed for at least 12 months with several outpatient visits. Results have been encouraging, showing the feasibility of telemedical care and good perception by patients and physicians.
Findings from four meta-analyses [26] [27] [28] [29] have shown that telemedical monitoring in chronic heart failure can reduce total mortality at a follow-up of 6-12 month, and can reduce the number and duration of hospital admissions for worsening heart failure. Since these meta-analyses were published, two prospective randomised prospective clinical trials of non-invasive approaches 24, 30 have not corroborated these findings for morbidity-related and mortality-related endpoints. The Sensitivity of the InSync Sentry OptiVol feature for the prediction of Heart Failure (SENSE-HF) trial 31 used an invasive approach but also did not find benefit. By contrast, the CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in New York Heart Association (NYHA) Class III Heart Failure Patients (CHAMPION) trial 32, 33 reported that wireless implantable haemodynamic monitoring of pulmonary artery pressure used to guide efforts for treatment optimisation significantly reduced the risk, compared with the control group, of hospital admissions due to heart failure in patients with chronic heart failure in the New York Heart Association (NYHA) functional class III. A review searching for reasons for these contrasting results found that they are most probably due to the fact that telemedical approaches vary, and that a meta-analysis that combines different approaches is probably inappropriate. 34 Further research is needed to better define the role of telemedicine in the care of acute and chronic heart failure patients. However, there are some emerging and consistent findings indicating that (a) only high-risk patients can profit from telemonitoring after hospitalisation for acute heart failure (they represent approximately one-sixth of the total heart failure population), and (b) remote patient management (RPM) has the potential to reduce mortality in heart failure patients up to 30% (Implant-based multiparameter telemonitoring of patients with heart failure -IN-TIME) and reduction of heart failure related hospitalisations and to improve quality of life (CHAMPION, TIM-HF). 24, 32, 33, 35 The actual European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of acute and chronic heart failure 36 recommend for the first time RPM of heart failure patients with a recommendation of grade II b. Further research to improve the burden of heart failure to patients and the community is better directed to define individual needs of heart failure patients and to study the potential benefits of RPM in heart failure patients to overcome regional differences in care (TIMI-HF II).
RPM with devices
The implantation of electronic cardiac devices such as pacemakers and ICDs has increased substantially over the last decade. Subsequent monitoring is an integral part of both device and patient care. Traditional practice consists of an in-clinical follow-up by physicians and/or device specialists to retrieve stored diagnostic data. This generates an enormous clinical workload which increases further when devices approach the moment when they need to be replaced, either electively, or in response to product advisories and recalls. The application of eHealth and telemedicine for RPM with implanted devices may provide mechanism(s) for facilitating these tasks. [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] Data are promising and it can be expected that remote monitoring systems will develop into dedicated monitoring and therapy platforms. We expect that data retrieved from these systems will form an integral part of the electronic patient record in the future as more and more outpatient clinic care will shift to personalised care provided at a distance, in other words at patients' homes. A provider perspective in five European countries on costs and net financial impact of follow-up with and without remote monitoring indicates that, for all patients as a whole, follow-up related costs for providers are no different for remote versus purely in-office follow-up, despite reorganised care. However, disparity in the impact on provider budget among different countries illustrates the need for proper reimbursement to ensure effective remote follow-up implementation.
Telerehabilitation
Exercise-based cardiac rehabilitation (CR) in hospital or in rehabilitation centres is the supervised intervention with the best scientific evidence: mortality reduction, symptom relief, smoking cessation and improved exercise capacity, risk factor modification and overall psychosocial wellbeing. 54 Based on the evidence-based benefits, CR is recommended by the AHA, the American College of Cardiology (ACC), and the ESC guidelines for patients with coronary artery disease (CAD). 55, 56 Despite evidence from trials and meta-analyses that CR 'works', only 15-30% of eligible patients participate. 57 This causes many to lament: 'Why don't more patients get referred to and use cardiac rehabilitation programs?'.
Using telehealth to deliver cardiac rehabilitation has been proposed as an innovative way of improving patients uptake, choice and access. 58, 59 Systematic reviews have shown the benefits of telehealth programmes when compared to usual care. [58] [59] [60] Telehealth exercise CR appears as effective as centre-based exercise CR for improving modifiable cardiovascular risk factors and functional capacity, and could enhance CR utilisation by providing additional options for patients who cannot attend centre-based exercise CR. 61 A recent cost-effectiveness analysis shows the addition of cardiac telerehabilitation to conventional centre-based CR to be more effective and efficient than centre-based CR alone. 62 These results are useful for policymakers responsible for deciding how limited health care resources should best be allocated in the era of exploding need. In Australia, a smartphone-based home care model improved post-myocardial infarction CR uptake, adherence and completion and may turn out to be another promising adjunct to centre-based rehabilitation. 63 Telerehabilitation may also support the patient in adhering to a healthier lifestyle (smoking cessation, activity tracking) and in adhering to medication use by integrating mobile phone text messages 64 and mHealth behaviour change interventions. 65 Furthermore, physical activity telemonitoring might be an effective intervention to increase the mediumterm clinical benefits of hospital-based CR. 66 Conclusions eHealth and telemedicine are rapidly evolving and will become an important component of today's medical care, but there is an important gap between technically driven progress and application-oriented research. Therefore, a great challenge for those involved in developing and implementing these new technologies will be to keep the main focus on patient's individual needs and not to be overwhelmed by the enormous speed of progress in technology and informatics and to carefully evaluate the evidence behind each new technology.
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